James has 10 years’ experience in the research and development of pharmaceuticals, in both the inflammation and radiopharmaceutical domains. He has published peer reviewed articles on the chemical synthesis and preclinical evaluation of several clinically studied compounds.
Currently, he works as a consultant helping (radiopharmaceutical) companies develop GMP-compliant equipment and processes. Previously, he worked as an innovation consultant, helping life science startups acquire dilutive and non-dilutive funding.
James holds a PhD (Medicinal and Radiopharmaceutical Chemistry) and a BSc Honours (Chemistry) from the University of Queensland and a BSc (Corporate Finance) from the University of Western Australia.